Researchers at Johns Hopkins Medicine have discovered a new role for the protein QRICH1 in regulating the immune system, specifically its influence on T cells.

Recently, a new oral medication has been released for treatment, called Leqselvi (deuruxolitinib). It's a JAK inhibitor made for those with severe alopecia, where the drug targets immune pathways involved in inflammation.

In South Korea, researchers developed a high-resolution genetic analysis tool in order to decode complex immune-related gene clusters that are linked to diseases like lupus.

A study published by BMJ Mental Health finds that people with autoimmune diseases are twice as likely to suffer from mood disorders such as depression, anxiety, or bipolar disorder.

Recently, various parts of the world have experienced an increase in extreme weather events, including heat waves, wildfires, and storms, which have caused power outages, air pollution, and floods.

A research team from Japan discovered that increased levels of certain immune cells may be responsible for the different levels of presentation of an autoimmune disease called systemic sclerosis (or scleroderma).

To receive an accurate diagnosis for celiac disease, many patients have to eat gluten regularly before undergoing lab tests.

Researchers at the University of Cambridge are conducting groundbreaking research to better understand patient experiences of flares in autoimmune diseases.

Living with an autoimmune disease can be isolating. It’s often hard to find others who truly understand the challenges of navigating symptoms, treatments, and the emotional toll that comes with them.

It is well known that a combination of factors, such as genetics, environmental triggers, and possible hormonal influences, can lead to the development of autoimmune diseases. Recent studies show that those with endometriosis are at an increased risk of developing an array of autoimmune diseases, such as rheumatoid arthritis, celiac disease, multiple sclerosis, and psoriasis.

Clinical trials are essential in advancing medical knowledge and creating new treatments. By evaluating the safety and efficacy of new therapies, clinical trials can help determine which treatments work best and which ones need to be improved, ultimately improving patient outcomes.

A recent study published in The Lancet Rheumatology identifies a promising new blood biomarker that might be able to identify those at risk for severe scleroderma.

Drug repurposing is a relatively new concept; that is, it emerged in the early 2000s but garnered attention during the COVID-19 pandemic. The objective of drug repurposing is to speed up the drug discovery process by finding new uses for already existing drugs.

Sjögren's Awareness Month is a time to raise awareness about the complexity and underdiagnosis of Sjögren's disease.

The mystery of how autoimmune diseases come about continues to unfold as researchers learn more about the various immunological responses and triggers. Scientists at Washington University School of Medicine in St. Louis collaborated with the Perelman School of Medicine at the University of Pennsylvania to identify a protein that drives immune response and overactivity.

In England, individuals with MS will soon have access to a take-home pill to manage relapses, eliminating the need for hospital visits for injections or infusions.